|
SSNA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.64969999947051E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.25889999999618E-05 |
| Normal-vs-Stage2 |
3.417700E-02 |
| Normal-vs-Stage3 |
8.567500E-04 |
| Normal-vs-Stage4 |
8.086200E-02 |
| Stage1-vs-Stage2 |
8.036800E-01 |
| Stage1-vs-Stage3 |
4.398200E-01 |
| Stage1-vs-Stage4 |
8.012400E-01 |
| Stage2-vs-Stage3 |
4.042200E-01 |
| Stage2-vs-Stage4 |
6.878400E-01 |
| Stage3-vs-Stage4 |
8.158800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.01939999999734E-06 |
| Normal-vs-AfricanAmerican |
3.225300E-04 |
| Normal-vs-Asian |
6.267800E-01 |
| Caucasian-vs-AfricanAmerican |
3.942400E-01 |
| Caucasian-vs-Asian |
4.162400E-02 |
| AfricanAmerican-vs-Asian |
1.724370E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.4864000003344E-07 |
| Normal-vs-Female |
3.763700E-03 |
| Male-vs-Female |
5.897400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.751600E-04 |
| Normal-vs-Extreme_Weight |
2.89259999952662E-07 |
| Normal-vs-Obese |
1.621420E-03 |
| Normal-vs-Extreme_Obese |
4.645600E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.590600E-01 |
| Normal_Weight-vs-Obese |
3.062400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.399200E-01 |
| Extreme_Weight-vs-Obese |
3.114000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.523800E-01 |
| Obese-vs-Extreme_Obese |
4.740400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.955900E-02 |
| Normal-vs-Age(41-60Yrs) |
3.65729999951547E-07 |
| Normal-vs-Age(61-80Yrs) |
1.020670E-04 |
| Normal-vs-Age(81-100Yrs) |
1.065690E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.947200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.765800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.864000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.970410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.387600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.707800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.56280030320033E-10 |
| Normal-VS-Type2 PRCC |
3.175500E-02 |
| Normal-VS-KIRP CIMP |
2.667800E-01 |
| Normal-VS-Unclassified PRCC |
6.561700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.159920E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.455800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.078100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.966400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.813000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.750800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.364500E-04 |
| Normal-vs-N1 |
3.240200E-02 |
| Normal-vs-N2 |
2.605400E-01 |
| N0-vs-N1 |
6.157200E-01 |
| N0-vs-N2 |
7.447400E-01 |
| N1-vs-N2 |
6.040200E-01 |
|
|
